Large Scale Genetic and –Omics Projects for Cardiovascular Disease and Diabetes Phenotypes

Speaker Biograpgy

Dr. Leslie Lange is a Professor of Medicine at the University of Colorado, Anschutz Medical Campus, and a member of the Colorado Center for Personalized Medicine (CCPM).  She is involved in a number of genetic consortia focused on cardiovascular disease, diabetes and lung disease, including the Trans-omics for Precision Medicine (TOPMed) program, the  Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortia, the FNIH-funded Accelerating Medicines Partnership (AMP) project T2D-GENES Knowledge Portal, and the Consortium on Asthma among African-ancestry Populations in the Americas (CAAPA).  Dr. Lange is actively involved in study design, statistical analysis, and interpretation of results in these studies, and has led efforts to harmonize phenotypes across several consortia. She is also involved in the CCPM Biobank, which is genotyping ~30,000 healthcare participants. Dr. Lange has a particular interest in studying genetics and other ‘omics in under-represented and minority populations, and she is a co-investigator for the Jackson Heart Study, the Reasons for Geographic and Racial Differences in Stroke (REGARDS) studies, and the Multi-ethnic Study of Atherosclerosis (MESA). 

Continuing Medical Education Credit

Continuing Medical Education (CME) credit is being offered for 2018 - 2019 Genetics and Genomics Grand Rounds series through the University of Arizona College of Medicine - Tucson.

The University of Arizona College of Medicine – Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Arizona College of Medicine – Tucson designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

2018 - 2019 Genetics and Genomics Grand Rounds Learning Objectives

1. Integrate advances in genetic diagnosis and treatment into the day-to-day practices of research and clinical care.
2. Order appropriate diagnostic evaluations for patients with hereditary medical conditions.

All Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they do not have any relevant financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.

Presented By